Tarsus Pharmaceuticals Inc. (TARS): Price and Financial Metrics
TARS Price/Volume Stats
Current price | $52.91 | 52-week high | $56.77 |
Prev. close | $52.00 | 52-week low | $18.99 |
Day low | $50.20 | Volume | 816,300 |
Day high | $53.62 | Avg. volume | 713,039 |
50-day MA | $46.21 | Dividend yield | N/A |
200-day MA | $34.92 | Market Cap | 2.02B |
TARS Stock Price Chart Interactive Chart >
Tarsus Pharmaceuticals Inc. (TARS) Company Bio
Tarsus is a clinical-stage biopharmaceutical company headquartered in Irvine, California. Tarsus was founded in 2017 to bring innovative therapies to a range of diseases in need of better solutions, starting with Demodex blepharitis and eye care.
TARS Price Returns
1-mo | 14.03% |
3-mo | 53.32% |
6-mo | 100.15% |
1-year | 166.95% |
3-year | 105.48% |
5-year | N/A |
YTD | 161.28% |
2023 | 38.13% |
2022 | -34.84% |
2021 | -45.56% |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...